Truffle Venture

French Artificial Heart Company Carmat Raises 33 Million Euros

Submitted by Jennifer L. Schenker on June 26, 2009

 CARMAT SAS, a Paris-based start-up developing an artificial heart for use in late-stage heart failure, announced that the European Commission has authorized the French state innovation agency Oséo to award €33 million in funding to its R&D program on the implantable device and the associated electrical supply and telediagnostic system. CARMAT SAS is leading the project, with support from four key industrial partners: Vignal Artru Industries (VAI), PaxiTech, Dédienne Santé and HEF R&D.Read more

French Companies Team On Next Paradigm In Drug Discovery

Submitted by Jennifer L. Schenker on June 15, 2009

Forget about personalized medicine. Pharnext, a Paris-based biotech company headed by a world reknowned pioneer in genome science, is  teaming with Ipsen, a speciality pharmaceutical group, on a different approach that could revolutionize drug discovery.Read more

Does France Hold The Key to the European Software Sector's Future?

Submitted by Jennifer L. Schenker on April 13, 2009

It is an all too familiar story.  European software companies grow to a certain size but have trouble scaling and are eventually bought by foreign, typically U.S. companies, leaving Europe with a dearth of global champions in a sector that is at the very core of the IT sector. But a French decree passed in late February aims to change the future direction of the European software industry.

Read more

Syndicate content